Search results
Results from the WOW.Com Content Network
Code Short-name Full name Listing date Issued capital Negotiable capital Industry Http English Chinese 000100: TCL: TCL集团: TCL Corporation: 30.01.2004: 13,549,648,507
In March 2005 the firm acquired Agis Industries Limited (traded as AGIS at the Tel Aviv Stock Exchange), an Israel-based generic pharmaceuticals company in an $850 million transaction. Agis was founded in 1983 by Mori Arkin, who developed his father's small drug import business into a multinational generic pharmaceutical company. As a result of ...
This is a non-diffusing parent category of Category:Companies in the SZSE 100 Index The contents of that subcategory can also be found within this category, or in diffusing subcategories of it. Wikimedia Commons has media related to Companies listed on the Shenzhen Stock Exchange .
The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical. Its H shares were listed on the Hong Kong Stock Exchange in 2009, [2] with its IPO price of HK$16 per share.
The drugmaker isn’t the only company to have had an executive disappear into China’s judicial system. Bao Fan, a star investment banker, was reported missing in February 2023 amid a wider anti ...
WuXi PharmaTech was founded in December 2000 in Shanghai by organic chemist Ge Li. [1] [2]The company opened chemistry facilities in Tianjin in 2007. In 2008, WuXi PharmaTech acquired AppTec Laboratory Services Inc., a US-based company founded in 2001 with expertise in medical-device and biologics testing and with facilities in St. Paul, MN; Philadelphia, PA; and Atlanta, GA.
A version of this post first appeared on TKer.co. Despite the looming threat of tariffs, the stock market continues to trade near record highs. This is a bit confounding since tariffs would be bad ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.